The largest database of trusted experimental protocols

36 protocols using ventana benchmark xt system

1

Immunohistochemical Analysis of Ki-67 and SF-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues were fixed in 10% buffered formalin and paraffin-embedded. Five-micrometer sections were hematoxylin and eosin (H/E) stained for histologic evaluation or used for immunohistochemistry. Immunohistochemical analysis with mouse anti-human Ki-67 monoclonal (Dako, Glostrup, Denmark) was performed with the Ventana Benchmark XT system (Ventana Medical Systems, Tucson, AZ, USA). Nuclei were hematoxylin counterstained. Ki-67 positive nuclei were counted on 1000 tumor cells in 3 tumors for each group. Negative controls were performed by omitting the primary antibodies. Immunohistochemical analysis with rabbit anti-human SF-1 polyclonal IgG (Upstate, Charlottesville, VA) was performed with the Ventana Benchmark XT system (Ventana Medical Systems, Tucson, AZ, USA).
+ Open protocol
+ Expand
2

Immunohistochemical Profiling of Lymphoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry (IHC) was performed using antibodies against MYC (clone EP121, Cell Marque, Rocklin, CA, USA), BCL2 (clone 124, DAKO, Carpinteria, CA, USA), BCL6 (clone LN22, Novocastra, Newcastle, United Kingdom), CD10 (clone 56C6, Novocastra), and MUM1 (clone Ma695, Novocastra). IHC staining was performed using the Ventana Benchmark XT system (Ventana Medical Systems, Tucson, AZ, USA) or a Bond-Max automated immunostainer (Leica Microsystems, Melbourne, Australia). Cell of origin was assessed according to the Hans criteria [11 (link)]. IHC score was determined to be the percentage of tumor cells with robust immunostaining evaluated by 10 % increments. Cutoff values (i.e. IHC scores) of ≥40 % for MYC, ≥30 and ≥60 % for BCL2 and ≥50 % for BCL6 were determined to have discriminant prognostic power based on the receiver operator characteristic (ROC) curves and were thus used for classifying cases into MYC-, BCL2- or BCL6-negative and-positive groups.
+ Open protocol
+ Expand
3

Immunohistochemical Profiling of Neuroendocrine Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed on formalin fixed tissue sections using the following antibodies at Mayo Clinic: OSCAR cytokeratin (clone OSCAR, predilute, BioLegend, Dedham, MA), chromogranin A (clone LK2H10, predilute, Ventana, AZ), CDX2 (clone EPR2764Y, 1/200, Cell Marque, Rocklin, CA), Islet 1 (clone 1H9, 1/800, abcam, Cambridge, MA), INSM1 (clone A8, 1/100, Santa Cruz, CA), Ki-67 (clone MIB-1, 1/20, Dako, Carpinteria, CA) and TTF-1 (clone SPT24, 1/100, Leica, Newcastle, UK). INSM1 and chromogranin were used as neuroendocrine markers. First, the sections were deparaffinized then rehydrated and stained online using antibody specific epitope retrieval techniques with the Ventana Benchmark XT system (Ventana, AZ).
Immunohistochemistry was performed at the University of Virginia Health System for T-PIT using the TBX19 antibody (clone T-PIT, 1/2000, Atlas Antibodies AB, Sweden) on the Ventana Benchmark platform. Immunohistochemistry for all markers was scored as follows: Negative (−) = 0% of cells staining and Positive (+) = > 10% of cells staining as an arbitrary minimum value. Automated Ki-67 analysis was performed using the digital method previously published by Kroneman et al. [18 (link)].
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of NOX5, ALK, and CD30

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin-fixed, paraffin-embedded tissue sections (4 μm thick) were analyzed by immunohistochemistry using a mouse monoclonal antibody specific for NOX5 [25 (link)], ALK (Dako M7195), or CD30 (Ventana Medical Systems, Tucson, AZ, USA, 790–2926). Staining was performed using the automated Ventana Discovery system for NOX5 and ALK or Ventana BenchMark XT system for CD30 (Ventana Medical Systems). Ventana reagents were used for all procedures. Briefly, slides were heated with cell conditioning solution for 36 min, for ALK and NOX5 antibodies, or for 64 min for CD30 (CC1; Tris-based buffer, pH 8.4). Primary antibodies were used at a dilution of 1/1000 or 1/50 for NOX5 or ALK, respectively. CD30 was used according to the manufacturer’s instructions. Detection of primary antibodies was carried out using the amplified DAB detection kit based on the conversion of diaminobenzidine to a dye with multimeric horseradish peroxidase.
+ Open protocol
+ Expand
5

PD-L1 Immunohistochemistry Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC staining was performed on the TMA slides using a PD-L1 clone (22C3; Dako, Carpentaria, CA, USA) and stained with Dako Autostainer (Dako) (Figure 1). IHC was also performed with an additional PD-L1 antibody (E1L3N; 1:50, Cell Signaling Technology, Danvers, MA, USA) and CD8 (1:100, Dako, Glostrup, Denmark) on the Ventana Benchmark XT system (Ventana, Tucson, AZ, USA), and visualized with a DAB detection kit (Ventana).
CD8+ TILs were evaluated in at least 3-4 representative high-power field (HPF) areas from each sample, and the mean CD8+ TILs count was scored using the following four-tier scoring system: no lymphocytes (0), 1-10/HPF (1), 11-50/HPF (2), >50/HPF (3) 23 .
We evaluated the PD-L1 expression in TCs or TILs separately, and then in both TC and /or TIL. The PD-L1 positivity was categorized based on the melanoma scoring system (MEL) as reported by Daud et al. 21 (link). The membranous expression in PD-L1 was graded on a five-point scale as follows: 0, no membranous staining; 1, >0%-<1%; 2, ≥1%-<10%; 3, ≥10%-<33%; 4, ≥33%-<66%; 5, ≥66%.
+ Open protocol
+ Expand
6

Lung Tissue Histology and NF-κB Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fixed lung tissue was paraffinized and sectioned (4–5 µm). Specimens were stained with H&E (hematoxylin-eosin). The pulmonary injury was estimated and semiquantitatively graded as previously described [10 (link)]. IHC staining for NF-κB p65 was automatically accomplished utilizing a Ventana BenchMark XT system (Ventana Medical Systems, Oro Valley, AZ, USA) as described previously [27 (link)]. Semi-quantitative analysis was performed by utilizing open-source digital image analysis software (ImageJ, 1.46a; NIH).
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of eIF4AI and eIF4E

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining for eIF4AI and eIF4E (anti-eIF4AI-antibody, 1:100 dilution, product# 2490; anti-eIF4E-antibody, 1:100 dilution, product# 9742; both Cell Signaling Technology, Danvers, MA, USA) was performed on 3 µm-thick sections of NB and NNT specimens using the VENTANA BenchMark XT system and the ultraView Universal DAB detection kit (Ventana Medical Systems, Inc., Oro Valley, AZ, USA). For epitope retrieval, CC1 mild was used. Cytoplasmic staining was evaluated by J.H. and P.C. and the staining intensity was scored as follows: score 0 was assigned to no staining, score 1 to weak, score 2 to moderate, and score 3 to strong staining.
+ Open protocol
+ Expand
8

Detecting HPV DNA in Small Cell Carcinoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three-micron sections containing small cell carcinoma and other types of epithelial tumors were examined for HPV DNA by ISH staining with INFORM® HPV III Family 16 and 6 Probe (Ventana Medical Systems, Inc., Tucson, AZ, USA) for high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 66) and low-risk HPV types (6 and 11), respectively. The ISH assay was performed according to the manufacturer’s protocol using the Ventana BenchMark XT system (Ventana Medical Systems, Inc.). Labeling was detected with the ISH iVIEW™ Blue Plus Detection Kit (Ventana Medical Systems, Inc.). The positive and negative controls were carried out using HPV quality control slides provided by Ventana Medical Systems, Inc. The HPV signals were detected in the nuclei of tumor cells, and the signal patterns were categorized as either episomal staining pattern or punctuate staining pattern. The former presents as a homogeneous globular navy-blue to black signal in the entire nuclei of tumor cells, and the latter shows single or multiple sparsely distributed and dot-like navy-blue punctae in the nuclei of the tumor cells.
+ Open protocol
+ Expand
9

Automated IHC Staining of NF-κB in Lung

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry (IHC) staining was automatically managed using Ventana Benchmark XT system (Ventana Medical Systems, Tucson, AZ, USA). The lung sections were immuno-stained using primary antibodies—rabbit polyclonal antibody to NF-κBp65 following previous procedures [1 (link),25 (link)].
+ Open protocol
+ Expand
10

Evaluating Chemotherapy Response in Ovarian Tumor

Check if the same lab product or an alternative is used in the 5 most similar protocols
All hematoxylin and eosin-stained tumor-containing ovarian tissue slides were independently reviewed. The chemotherapy response score (CRS) was evaluated according to a previous study [25 (link)]. Briefly, CRS 1 indicated no or minimal tumor response, CRS 2 indicated appreciable tumor response amid a viable tumor that is readily identifiable, and CRS 3 indicated complete or near-complete response with no residual tumor or nodules up to a maximum size of 2 mm.
Conventional IHC analysis was performed on whole sections of FFPE tumor tissue blocks. Four-μm-thick sections of surgically resected tissues were immunostained using a Ventana BenchMark XT system automated stainer (Ventana Medical Systems, Tucson, AZ, USA) according to the manufacturer’s recommendations. The sections were incubated with antibodies against RAD51 (clone 14B4; GeneTex, Alton Pkwy Irvine, CA, USA), geminin (clone 10802-1-AP; ProteinTech Group, Chicago, IL, USA), and γH2AX (clone JBW301, Sigma-Aldrich, Dorset, UK). The detailed protocols are summarized in Table S1. After chromogenic visualization using an UltraView Universal DAB Detection Kit (Ventana Medical Systems), the slices were counterstained with hematoxylin, dehydrated in graded alcohols and xylene, and embedded in mounting solution. Appropriate positive and negative controls were concurrently stained to validate the staining method.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!